Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Chromogenic Agar Medium Identifies Aeromonas in Fecal Samples

By LabMedica International staff writers
Posted on 25 Jun 2012
Chromogenic agar medium has been found useful for the isolation, differentiation, and potential identification of Aeromonas spp. More...
isolated from several sources.

Chromogenic media have facilitated the identification of pathogenic organisms at the genus level and in some cases at the species level, thus requiring a shorter testing time and simplifying the detection of target bacteria and the interpretation of primary culture results.

Medical microbiologists at National Polytechnic Institute (México) evaluated the microbiological performance of a chromogenic agar medium, using the Miles and Misra method and the Mossel ecometric technique. A total of 62 strains were tested, including 23 isolated from gastrointestinal infection, 13 type strains from the Spanish type culture collection of the Aeromonas genus, 12 strains isolated from water, nine isolated from frozen fish, and six other strains from the American type culture collection.

The medium CromoCen AGN agar (BioCen; Havana, Cuba) was designed as a chromogenic agar medium for the rapid and simultaneous identification of Aeromonas and Pseudomonas and for the identification and/or enumeration of Salmonella, Escherichia coli, and coliform bacteria. Two control media, MacConkey (Bioxon; Mexico City, Mexico), and Ryan Aeromonas (Oxoid Ltd.; Basingstoke, UK) were used for the comparative evaluation using the ecometric test.

CromoCen AGN agar medium was also assessed for the potential identification of Aeromonas spp. in fecal samples that were collected from asymptomatic schoolchildren. Out of 106 processed stool cultures, five were putatively positive (4.7%) and identified as Aeromonas colonies. These five strains were pale or light green in color, and only four had evident proteolytic activity. The CromoCen AGN exhibited 94.73% sensitivity and 100% specificity for the various samples

The authors concluded that if the incidence of Aeromonas diarrhea in the patient population of a given laboratory is high, the routine use of CromoCen AGN agar medium is warranted. This agar has a relatively high plating efficiency for most strains, can simplify the initial genus identification prior to genetic identification. CromoCen AGN agar is useful for the inhibition of Gram-positive bacteria, is easy to use, is simple to interpret and suitable for the identification of the Aeromonas genus. However, due to the incidence of false negative results, it should not be used for species identification. The study was published online on April 27, 2012, in the Journal of Microbiological Methods.

Related Links:

National Polytechnic Institute
Bioxon
Oxoid Ltd.



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.